Are Anti-Infectious Vaccinations Safe and Effective in Patients with Autoimmunity?

REFERENCES

• Gluck T, Muller-Landner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008; 46: 1459–1465.
   PubMed Web of Science ®Google Scholar
• Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing clinical guidelines. West J Med 1999; 170: 348–351.
   PubMedGoogle Scholar
• Davis LE, Hersh EM, Curtis JE, Immune status of patients with multiple sclerosis. Analysis of primary and established immune responses in 24 patients. Neurology 1972; 22: 989–997.
   Google Scholar
• Sibley WA, Bamford CR, Laguna JF. Influenza vaccination in patients with multiple sclerosis. JAMA 1976; 236: 1965–1966.
   Google Scholar
• Myers LW, Ellison GW, Lucia M, Swine influenza virus vaccination in patients with multiple sclerosis. J Infect Dis 1977; 136: S546–S554.
   Google Scholar
• Bamford CR, Sibley WA, Laguna JF. Swine influenza vaccination in patients with multiple sclerosis. Arch Neurol 1978; 35: 242–243.
   Google Scholar
• Michielsens B, Wilms G, Marchal G, Carton H. Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination. Eur Neurol 1990; 30: 258–259.
   PubMed Web of Science ®Google Scholar
• Salvetti M, Pisani A, Bastianello S, Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination. J Neurol 1995; 242: 143–146.
   Google Scholar
• Mokhtarian F, Shirazian D, Morgante L, Influenza virus vaccination of patients with multiple sclerosis. Mult Scler 1997; 3: 243–247.
   Google Scholar
• Miller AE, Morgante LA, Buchwald LY, A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology 1997; 48: 312–314.
   Google Scholar
• Keyser J De, Zwanikken C, Boon M. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis. J Neurol Sci 1998; 159: 51–53.
   Google Scholar
• Moriabadi NF, Niewiesk S, Kruse N, Influenza vaccination in MS: Absence of T-cell response against white matter proteins. Neurology 2001; 56: 938–943.
   Google Scholar
• Confavreux C, Suissa S, Saddier P, Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 2001; 344: 319–326.
   PubMed Web of Science ®Google Scholar
• Schwid SR, Decker MD, Lopez-Bresnahan M, Rebif-Influenza Vaccine Study Investigators. Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a. Neurology 2005; 65: 1964–1966.
   PubMed Web of Science ®Google Scholar
• Keyser J De. Safety of tetanus vaccination in relapsing-remitting multiple sclerosis. Infection 1998; 26: 319.
   Google Scholar
• Baumhackl U, Franta C, Retzl J, A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis. Vaccine 2003; 21(Suppl 1):S56–S61.
   Google Scholar
• Herroelen L, Keyser J De, Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 1991; 338: 1174–1175.
   PubMed Web of Science ®Google Scholar
• Gout O, Lyon Caen O. Sclerotic plaques and vaccination against hepatitis B. Rev Neurol 1998; 154: 205–207.
   PubMed Web of Science ®Google Scholar
• Williams GW, Steinberg AD, Reinertsen JL, Influenza immunization in systemic lupus erythematosus: A double-blind trial. Ann Int Med 1978; 88: 729–734.
   PubMedGoogle Scholar
• Brodman R, Gilfillan R, Glass D, Schur PH. Influenza vaccine response in systemic lupus erythematosus. Ann Int Med 1978; 88: 735–740.
   PubMed Web of Science ®Google Scholar
• Louie JS, Nies KM, Shoji KT, Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Int Med 1978; 88: 790–792.
   PubMed Web of Science ®Google Scholar
• Ristow SC, Douglas RG, Condemi JJ. Influenza vaccination of patients with systemic lupus erythematosus. Ann Int Med 1978; 88: 786–789.
   PubMed Web of Science ®Google Scholar
• Herron A, Dettleff G, Hixon B, Influenza vaccination in patients with rheumatic diseases. JAMA 1979; 242: 53–56.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L, Cambridge G, Corcoran T, In vitro response to influenza immunisation by peripheral blood mononuclear cells from patients with systemic lupus erythematosus and other autoimmune diseases. Ann Rheum Dis 1988; 47: 532–535.
   Google Scholar
• Turner-Stokes L, Cambridge G, Snaith ML. In vitro lymph node and peripheral blood lymphocyte responses to influenza immunization in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1989; 7: 71–74.
   Google Scholar
• Abu-Shakra M, Zalmanson S, Neumann L, Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol 2000; 27: 1681–1685.
   PubMed Web of Science ®Google Scholar
• Abu-Shakra M, Press J, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: Effects on generation of autoantibodies. Clin Rheumatol 2002; 21: 369–372.
   PubMedGoogle Scholar
• Abu-ShakraM, Press J, Varsano N, Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 2002; 29: 2555–2557.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630–640.
   PubMed Web of Science ®Google Scholar
• Mercado U, Acosta H, Avendano L. Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 2004; 56: 16–20.
   PubMedGoogle Scholar
• Holvast A, Huckriede A, Wilschut J, Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 2006; 65: 913–918.
   PubMed Web of Science ®Google Scholar
• Porto F Del, Laganà B, Biselli R, Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine 2006; 24: 3217–3223. Epub 2006 Jan 23.
   Google Scholar
• Tarján P, Sipka S, Lakos G, Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 2006; 35: 241–249.
   PubMed Web of Science ®Google Scholar
• Stojanovich L. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin Dev Immunol 2006; 13: 373–375.
   PubMedGoogle Scholar
• Stratta P, Cremona R, Lazzarich E, Life-threatening systemic flare-up of systemic lupus erythematosus following influenza vaccination. Lupus 2008; 17: 67–68.
   Google Scholar
• Holvast A, Assen S van, HaanA de, Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: An open, prospective, controlled study. Rheumatology 2009; 48: 1294–1299. Epub 2009 Aug 19.
   Google Scholar
• Holvast A, Assen S van, Haan A de, Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus. Arthritis Rheum 2009; 60: 2438–2447.
   PubMedGoogle Scholar
• Wallin L, Quintilio W, Locatelli F, Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients. Acta Reumatol Port 2009; 34: 498–502.
   PubMed Web of Science ®Google Scholar
• Wisik-Szewczyk E, Romanowska M, Mielnik P, Anti-influenza vaccination in systemic lupus erythematosus patients: An analysis of specific humoral response and vaccination safety. Clin Rheumatol. DOI 10.1007/s10067-010-1373-y
   Google Scholar
• Klippel JH, Karsh J, Stahl NI, A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1321–1325.
   PubMed Web of Science ®Google Scholar
• Jarrett MP, Schiffman G, Barland P, Grayzel AI. Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum 1980; 23: 1287–1293.
   PubMed Web of Science ®Google Scholar
• McDonald E, Jarret MP, Schiffman G, Grayzel AI. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J Rheumatol 1984; 11: 306–308.
   PubMed Web of Science ®Google Scholar
• Croft SM, Schiffman G, Snyder E, Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus. J Rheumatol 1984; 11: 141–146.
   Google Scholar
• Lipnick RN, Karsh J, Stahl NI, Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives. J Rheumatol 1985; 12: 1118–1122.
   PubMed Web of Science ®Google Scholar
• Battafarano DF, Battafarano NJ, Larsen L, Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum 1998; 41: 1828–1834.
   PubMed Web of Science ®Google Scholar
• Tarján P, Sipka S, Maródi L, No short-term immunological effects of Pneumococcus vaccination in patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 211–215.
   PubMed Web of Science ®Google Scholar
• Elkayam O, Paran D, Caspi D, Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002; 34: 147–153. Epub 2001 Dec 4.
   PubMedGoogle Scholar
• Elkayam O, Paran D, Burke M, Pneumococcal vaccination of patients with systemic lupus erythematosus: Effects on generation of autoantibodies. Autoimmunity 2005; 38: 493–496.
   PubMed Web of Science ®Google Scholar
• Pisoni C, Sarano J, Benchetrit G, Antipneumococcal vaccination in patient with systemic lupus erythematosus. Medicina 2003; 63: 388–392.
   PubMed Web of Science ®Google Scholar
• Moxey-Mims MM, Preston K, Fivush B, McCurdy F. Heptavax-B in pediatric dialysis patients: Effect of systemic lupus erythematosus. Chesapeake Pediatric Nephrology Study Group. Pediatr Nephrol 1990; 4: 171–173.
   Google Scholar
• Fleming SJ, Moran DM, Cooksley WG, Faoagali JL. Poor response to a recombinant hepatitis B vaccine in dialysis patients. J Infect 1991; 22: 251–257.
   PubMed Web of Science ®Google Scholar
• Gartner S, Emlen W. HBV vaccination of SLE patients [abstract]. Arthritis Rheum 1996; 39(Suppl. 9):S291.
   Google Scholar
• SenécalJL. Severe exacerbation of systemic lupus erythematosus after hepatitis B vaccination and importance of pneumococcal vaccination in patients with autosplenectomy: Comment on the article by Battafarano et al. Arthritis Rheum 1999; 42: 1304–1308.
   Google Scholar
• Maillefert JF, Sibilia J, Toussirot E, Rheumatic disorders developed after hepatitis B vaccination. Rheumatology 1999; 38: 978–983.
   PubMed Web of Science ®Google Scholar
• Kuruma KA, Borba EF, Lopes MH, Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus 2007; 16: 350–354.
   PubMed Web of Science ®Google Scholar
• Devey ME, Bleasdale K, Isenberg DA. Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1987; 68: 562–569.
   PubMed Web of Science ®Google Scholar
• Kashef S, Ghazizadeh F, Derakhshan A, Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid. Iran J Immunol 2008; 5: 181–184.
   PubMedGoogle Scholar
• Chalmers A, Scheifele D, Patterson C, Immunization of patients with rheumatoid arthritis against influenza: A study of vaccine safety and immunogenicity. J Rheumatol 1994; 21: 1203–1206.
   PubMed Web of Science ®Google Scholar
• Cimmino MA, Seriolo B, Accardo S. Influenza vaccination in rheumatoid arthritis. J Rheumatol 1995; 22: 1802–1803.
   Google Scholar
• Francioni C, Rosi P, Fioravanti A, Vaccination against influenza in patients with rheumatoid arthritis: Clinical and antibody response. Recenti Prog Med 1996; 87: 145–149.
   Google Scholar
• Iyngkaran P, Limaye V, Hill C, Rheumatoid vasculitis following influenza vaccination. Rheumatology 2003; 42: 907–909.
   Google Scholar
• Fomin I, Caspi D, Levy V, Vaccination against influenza in rheumatoid arthritis: The effect of disease modifying drugs, including TNF a blockers. Ann Rheum Dis 2006; 65: 191–194.
   PubMed Web of Science ®Google Scholar
• Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology 2007; 46: 608–611.
   PubMed Web of Science ®Google Scholar
• Kaine JL, Kivitz AJ, Birbara C, Luo AY. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 2007; 34: 272–279.
   PubMed Web of Science ®Google Scholar
• Kubota T, Nii T, Nanki T, Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis. Mod Rheumatol 2007; 17: 531–533. Epub 2007 Dec 20.
   PubMedGoogle Scholar
• Gelinck LB, van der bijl AE, Beyer WE, The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008; 67: 713–716. Epub 2007 Oct 26.
   PubMed Web of Science ®Google Scholar
• Elkayam O, Bashkin A, Mandelboim M, The effect of Infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2009 Feb 24. [Epub ahead of print]
   Google Scholar
• Salemi S, Picchianti-Diamanti A, Germano V, Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: Safety and immunogenicity. Clin Immunol 2010; 134: 113–120. Retrieved 20 Oct 2009.
   PubMed Web of Science ®Google Scholar
• Nii T, Kubota T, Nanki T, Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers. Mod Rheumatol 2009; 19: 216–218. Epub 2008 Nov 18.
   PubMed Web of Science ®Google Scholar
• Gelinck LB, Teng YK, Rimmelzwaan GF, Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis 2007; 66: 1402–1403.
   PubMed Web of Science ®Google Scholar
• Oren S, Mandelboim M, Braun-Moscovici Y, Vaccination against influenza in patients with rheumatoid arthritis: The effect of rituximab on the humoral response. Ann Rheum Dis 2008; 67: 937–941. Epub 2007 Nov 2.
   PubMed Web of Science ®Google Scholar
• van Assen S, Holvast A, Benne CA, Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with Rituximab. Arthritis Rheum 2010; 62: 75–81.
   PubMed Web of Science ®Google Scholar
• O’Dell JR, Gilg J, Palmer W, Pneumococcal vaccine in rheumatoid arthritis. J Clin Rheumatol 1996; 2: 59–63.
   Google Scholar
• Elkayam O, Caspi D, Reitblatt T, The effect of tumour necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004; 33: 283–288.
   PubMed Web of Science ®Google Scholar
• Kapetanovic MC, Saxne T, Sjoholm A, Influence of methotrexate, TNF-blockers and prednisolone on antibody responses to pneumococcal vaccine in patients with rheumatoid arthritis. Rheumatology 2006; 45: 106–111.
   PubMed Web of Science ®Google Scholar
• Visvanathan S, Keenan GF, Baker DG, Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 2007; 34: 952–957.
   PubMed Web of Science ®Google Scholar
• Gelinck LBS, Van Der Biji AE, Visser LG, Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23-valent pneumococcal polysaccharide vaccine. Vaccine 2008; 26: 3528–3533.
   PubMed Web of Science ®Google Scholar
• Bingham CO III, Looney RJ, Deodhar A, Immunization response in rheumatoid arthritis patients treated with Rituximab. Results from a controlled clinical trial. Arthritis Rheum 2010; 62: 64–74.
   PubMed Web of Science ®Google Scholar
• Karsh JB, Pavlidis N, Schiffman G, Moutsopoulos HM. Immunization of patients with Sjogren syndrome with pneumococcal polysaccharide vaccine. Arthritis Rheum 1980; 23: 1294–1297.
   PubMed Web of Science ®Google Scholar
• Palit J, Chattopadhyay C, Malaviya AN, Some immunological parameters in rheumatoid arthritis from India. Biomedicine 1977; 27: 70–73.
   Google Scholar
• Elkayam O, Yaron M, Caspi D. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Ann Rheum Dis 2002; 61: 623–625.
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Gale E, Visalli N, The immune response to influenza vaccination in diabetic patients. Diabetologia 1986; 29: 850–854.
   Google Scholar
• Diepersloot R, Bouter K, Beyer W, Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 1987; 30: 397–401.
   PubMed Web of Science ®Google Scholar
• Diepersloot RJ, Bouter KP, van Beek R, Cytotoxic T-cell response to influenza A subunit vaccine in patients with type 1 diabetes mellitus. Neth J Med 1989; 35: 68–75.
   PubMed Web of Science ®Google Scholar
• Ruben FL, Fireman P, Porte RE La, Immune responses to killed influenza vaccine in patients with type 1 diabetes. Altered responses associated with HLA-DR3 and DR4. J Lab Clin Med 1998; 41: 1828–1834.
   Google Scholar
• El-Madhun AS, Cox RJ, Seime A, Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: Results from a pilot study. Vaccine 1998; 16: 156–160.
   Google Scholar
• Zuccotti GV, Scaramuzza A, Riboni S, Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Vaccine 2009; 27: 5357–5362. Epub 2009 Jul 14.
   PubMed Web of Science ®Google Scholar
• Kostinov MP, Skochilova TV, Vorob’eva VA, Autoantibodies after vaccination against pneumococcal and influenza infections in children and adolescents with type I diabetes mellitus. Zh Mikrobiol Epidemiol Immunobiol 2009; 2: 53–57.
   Google Scholar
• Pozzilli P, Arduini P, Visalli N, Reduced protection against hepatitis B virus following vaccination in patients with Type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30: 817–819.
   PubMed Web of Science ®Google Scholar
• Pagani S, Cruciani L, Chianelli M, Thymopentin administration and increase of seroconversion after B-hepatitis vaccine in diabetic patients. Diabetes Res 1989; 12: 199–201.
   Google Scholar
• Wismans PJ, Hattum J van, Gast G de, A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls. J Med Virol 1991; 35: 216–222.
   Google Scholar
• Bouter KP, Diepersloot RJ, Wismans PJ, Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type 1 diabetes mellitus. Diabet Med 1992; 9: 66–69.
   PubMedGoogle Scholar
• Volti S Li, Caruso-Nicoletti M, Biazzo F, Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus. Arch Dis Child 1998; 78: 54–57.
   Google Scholar
• Arslanoğlu I, Cetin B, Işgüven P, Karavuş M. Anti-HBs response to standard hepatitis B vaccination in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab 2002; 15: 389–395.
   PubMed Web of Science ®Google Scholar
• Kostinov MP Tarasova AA. Intensity of immunity in children with type 1 diabetes mellitus vaccinated against hepatitis B. Zh Mikrobiol Epidemiol Immunobiol 2008; 5: 61–65.
   Google Scholar
• Eibl N, Spatz M, Fischer GF, Impaired primary immune response in type-1 diabetes: Results from a controlled vaccination study. Clin Immunol 2002; 103: 249–259.
   PubMed Web of Science ®Google Scholar
• Tarasova AA, Kostinov MP, Iastrebova NE, Skochilova TV. Effect of vaccination against pneumococcal infection in children with type 1 diabetes mellitus. Zh Mikrobiol Epidemiol Immunobiol 2007; 6: 45–49.
   Google Scholar
• Malleson PN, Tekano JL, Scheifele DW, Weber JM. Influenza immunization in children with chronic arthritis: A prospective study. J Rheumatol 1993; 20: 1769–1773.
   PubMed Web of Science ®Google Scholar
• Olson NY, Lindsley CB. Influenza immunization in children with chronic arthritis. J Rheumatol 1994; 21: 1581–1582.
   Google Scholar
• Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin Exp Rheumatol 2001; 19: 589–594.
   PubMed Web of Science ®Google Scholar
• Kasapçopur O, Cullu F, Kamburoğlu-Goksel A, Hepatitis B vaccination in children with juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63: 1128–1130.
   PubMed Web of Science ®Google Scholar
• Zonneveld-Huijssoon E, Ronaghy A, Van Rossum MA, Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis. Arthritis Rheum 2007; 56: 639–646.
   Google Scholar
• Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E, Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis. Ann Rheum Dis 2007; 66: 1384–1387. Epub 2007 Feb 6.
   PubMed Web of Science ®Google Scholar
• Borte S, Liebert UG, Borte M, Sack U. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology 2009; 48: 144–148. Epub 2008 Dec 11.
   PubMed Web of Science ®Google Scholar
• Korematsu S, Miyahara H, Kawano T, A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period. Vaccine 2009; 27: 5041–5042. Epub 2009 Jul 2.
   PubMed Web of Science ®Google Scholar
• Damjanov I, Amaid J. Progression of renal disease in Henoch-Shönlein purpura after influenza vaccination. JAMA 1979; 242: 255.
   Google Scholar
• Cannata J, Cuesta V, Peral V, Reactivation of vasculitis after influenza vaccination. Br Med J 1981; 283: 526.
   Google Scholar
• Mormile R, D'Alterio V, Treccagnoli G, Sorrentino P. Henoch-Shönlein purpura with anti-phospholipid antibodies after influenza vaccination: How fearful is it in children? Vaccine 2004; 23: 567–568.
   PubMedGoogle Scholar
• Zycinska K, Romanowska M, Nowak I, Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis. J Physiol Pharmacol 2007; 58: 819–828.
   Google Scholar
• Stassen PM, Sanders JF, Kallenberg CGM, Stegeman CA. Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2008; 23: 654–658. Epub 2007 Oct 2.
   Google Scholar
• Birck R, Kaelsch I, Schnuelle P, ANCA-associated vasculitis following influenza vaccination: Causal association or mere coincidence? J Clin Rheumatol 2009; 15: 289–291.
   PubMed Web of Science ®Google Scholar
• Holvast A, Stegeman CA, Benne CA, Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination. Ann Rheum Dis 2009; 68: 873–878.
   Google Scholar
• Erkek E, Ayaslioglu E, Erkek AB, Response to vaccination against hepatitis B in patients with Behcet's disease. J Gastroenterol Hepatol 2005; 20: 1508–1511.
   PubMed Web of Science ®Google Scholar
• Zinman L, Thoma J, Kwong JC, Safety of influenza vaccination in patients with myasthenia gravis: A population-based study. Muscle Nerve 2009; 40: 947–951.
   Google Scholar
• Benz R, Krause R, Taverna C. Immune thrombocytopenic purpura reactivation after tick-borne encephalitis vaccination. Vaccine 2009; 27: 5172–5173.
   Google Scholar
• Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, October 2007–September 2008. Ann Intern Med 2008; 147: 725–729.
   Google Scholar
• Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009. Ann Intern Med 2008; 150: 40–44.
   Google Scholar
• Bridges MJ, Coady D, Kelly CA, Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2003; 62: 685.
   Google Scholar
• Fahy WA, Farnworth E, Yeldrem KP, Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy. Rheumatology 2006; 45: 912–913.
   Google Scholar
• Pradeep J, Watts R, Clunie G. Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2007; 66: 837–838.
   PubMed Web of Science ®Google Scholar
• Sowden E, Mitchell W. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disord 2007; 8: 58.
   Google Scholar
• Ledwich LJ, Harrington TM, Ayoub WT, Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert. Arthritis & Rheumatism 2009; 61: 1505–1510. DOI 10.1002/art.24873
   Google Scholar
• Maya R, Gershwin ME, Shoenfeld Y. Hepatitis B virus (HBV) and autoimmune disease. Clinic Rev Allerg Immunol 2008; 34: 85–102. DOI 10.1007/s12016-007-8013-6
   Google Scholar
• Girard M. Autoimmune hazards of hepatitis B vaccine. Autoimmunity Reviews 2005; 4: 96–100.
   PubMed Web of Science ®Google Scholar
• MMWR. Measles, Mumps, and Rubella—Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 1998; 47(RR-8):1–57.
   Google Scholar
• Kuroda Y, Nacionales DC, Akaogi J, Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother 2004; 58: 325–337.
   PubMed Web of Science ®Google Scholar
• Brezinschek HP, Hofstaetter T, Leeb BF, Immunization of patients with rheumatoid arthritis with anti-tumour necrosis factor therapy and methotrexate. Curr Opin Rheumatol 2008; 20: 295–299.
   Google Scholar
• Monto AS, Ohmit SE, Petrie JG, Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med. 2009; 361: 1260–1267.
   PubMed Web of Science ®Google Scholar
• Cornu C, Yzebe D, Leophonte P, Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: A meta-analysis of randomized trials. Vaccine 2001; 19: 4780–4790.
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: A review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9: 493–504.
   PubMed Web of Science ®Google Scholar
• Maruyama T, Taguchi O, Niederman MS, Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: Double blind, randomised and placebo controlled trial. BMJ 2010; 340: c1004. DOI:10.1136/bmj.c1004
   PubMed Web of Science ®Google Scholar
• MMWR. Recommended adult immunization schedule—United States 2009. 2009; 57: Q-1–Q-4.
   Google Scholar